Literature DB >> 11268764

[Practical application of the CERAD test battery as a neuropsychological dementia screening test].

W Satzger1, H Hampel, F Padberg, K Bürger, T Nolde, G Ingrassia, R R Engel.   

Abstract

The CERAD neuropsychological test battery is becoming the standard measure for screening cognitive deficits associated with dementia. The seven subtests of the CERAD battery (Mini-Mental State Examination or MMSE, verbal fluency, Modified Boston Naming Test or MBNT, construction ability, learning of word lists, recall, and recognition), a short test of crystallized intelligence (vocabulary test or WST), and a simple test of visuo-motor tracking (number relation test-G or ZVT-G) were applied to 30 healthy control subjects, 49 depressed patients, and 98 mildly to severely demented patients. All subtests of the CERAD battery separated controls from mildly demented patients. Overall, depressed patients scored between controls and mildly demented patients. Score differences between depressed patients and mildly demented patients were significant for MMSE, learning and recall of the word list, verbal fluency, and MBNT. This paper contains a profile sheet for the CERAD battery developed according to published norms that allows rapid transformation of test results into a scaled graphical representation.

Entities:  

Mesh:

Year:  2001        PMID: 11268764     DOI: 10.1007/s001150050739

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  8 in total

1.  [CERAD-NP battery: Age-, gender- and education-specific reference values for selected subtests. Results of the German Study on Ageing, Cognition and Dementia in Primary Care Patients (AgeCoDe)].

Authors:  T Luck; S G Riedel-Heller; B Wiese; J Stein; S Weyerer; J Werle; H Kaduszkiewicz; M Wagner; E Mösch; T Zimmermann; W Maier; H Bickel; H van den Bussche; F Jessen; A Fuchs; M Pentzek
Journal:  Z Gerontol Geriatr       Date:  2009-07-30       Impact factor: 1.281

2.  [Implementation of the German S3 guidelines on dementia in clinical practice: wish or reality?]

Authors:  H Lohmann; F Kulessa; H Holling; A Johnen; S Reul; G Lueg; T Duning
Journal:  Nervenarzt       Date:  2017-08       Impact factor: 1.214

3.  [Well-being and psychosocial activities in nursing homes : Survey of residents].

Authors:  R Cramer-Ebner; C Dorn; A Feilcke; I Hach
Journal:  Z Gerontol Geriatr       Date:  2016-06-28       Impact factor: 1.281

4.  [CERAD and NOSGER. Comparing predictive scales for dementia in a Swiss gerontopsychiatric patient population].

Authors:  G Künig; A Kaldune; V Stief; M Jäger; D Hell; J Endrass; U Schreiter Gasser
Journal:  Nervenarzt       Date:  2007-03       Impact factor: 1.214

5.  [Correlation of mental activity with cognitive functions  in mild cognitive impairment and early stage dementia].

Authors:  M Defrancesco; G Kemmler; R Huber; E A Deisenhammer
Journal:  Nervenarzt       Date:  2014-03       Impact factor: 1.214

6.  Changes in white matter integrity before conversion from mild cognitive impairment to Alzheimer's disease.

Authors:  Michaela Defrancesco; Karl Egger; Josef Marksteiner; Regina Esterhammer; Hartmann Hinterhuber; Eberhard A Deisenhammer; Michael Schocke
Journal:  PLoS One       Date:  2014-08-25       Impact factor: 3.240

7.  AgeWell.de - study protocol of a pragmatic multi-center cluster-randomized controlled prevention trial against cognitive decline in older primary care patients.

Authors:  Andrea Zülke; Tobias Luck; Alexander Pabst; Wolfgang Hoffmann; Jochen René Thyrian; Jochen Gensichen; Hanna Kaduszkiewicz; Hans-Helmut König; Walter E Haefeli; David Czock; Birgitt Wiese; Thomas Frese; Susanne Röhr; Steffi G Riedel-Heller
Journal:  BMC Geriatr       Date:  2019-08-01       Impact factor: 3.921

8.  Association between mental demands at work and cognitive functioning in the general population - results of the health study of the Leipzig research center for civilization diseases (LIFE).

Authors:  Francisca S Then; Tobias Luck; Melanie Luppa; Katrin Arélin; Matthias L Schroeter; Christoph Engel; Markus Löffler; Joachim Thiery; Arno Villringer; Steffi G Riedel-Heller
Journal:  J Occup Med Toxicol       Date:  2014-05-28       Impact factor: 2.646

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.